Tafazzin, Protein G4.5 or Transcriptional Coactivator With PDZ-Binding Motif is encoded by the gene TAZ. Tafazzin is a mitochondrial transacylase which is involved in cardiolipin remodeling. Tafazzin is expressed in cardiac and skeletal muscle. Diseases associated with this gene include Barth Syndrome and Atrial Standstill.
Purified by Protein A chromatography
Lot dependent: provided at 0.3-0.5 mg/mL
Monoclonal
N173B/13
IgG2b
ICC
Mouse
TAZ EFE2 G4.5
30 kDa
Fusion protein amino acids 1-262 (full-length) of human Tafazzin with exon 5 deleted (accession number Q16635-3) produced recombinantly in E. Coli
Human
Human
AB_2939729
Aliquot and store at ≤ -20°C for long term storage. For short term storage, store at 2-8°C. For maximum recovery of product, centrifuge the vial prior to removing the cap.
Liquid
Produced by in vitro bioreactor culture of hybridoma line followed by Protein A affinity chromatography and conjugation of purified mAb. Purified mAbs are >90% specific antibody.
PBS with 0.09% azide
FL550 Ex: 550 nm, Em: 575 nm
No cross-reactivity reported
Each new lot of antibody is quality control tested on cells overexpressing target protein and confirmed to give the expected staining pattern.
These antibodies are to be used as research laboratory reagents and are not for use as diagnostic or therapeutic reagents in humans.
